Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec Earns Boehringer Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec Earns Boehringer Milestone

Transitions oncology program into preclinical profiling

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG has reached a milestone in its research alliance with Boehringer Ingelheim, triggering a payment of $3.2 million to Evotec. The milestone was for the transition of an oncology program into preclinical profiling.
 
Dr. Mario Polywka, chief operating officer of Evotec, said “This is the seventeenth milestone achieved as part of our alliance with Boehringer Ingelheim and represents an important transition of a compound into pre-clinical profiling. We are pleased the collaborative efforts of teams from Evotec and Boehringer Ingelheim continue to show success in progressing compounds towards the clinic.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics